194 related articles for article (PubMed ID: 25182141)
1. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis.
Kalantari S; Nafar M; Rutishauser D; Samavat S; Rezaei-Tavirani M; Yang H; Zubarev RA
BMC Nephrol; 2014 Sep; 15():141. PubMed ID: 25182141
[TBL] [Abstract][Full Text] [Related]
2. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
[TBL] [Abstract][Full Text] [Related]
3. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomic analysis of children FSGS FFPE tissues.
Ni J; Tian S; Bai L; Lv Q; Liu J; Liu J; Fang Y; Zhai Y; Shen Q; Rao J; Ding C; Xu H
BMC Pediatr; 2022 Dec; 22(1):707. PubMed ID: 36503536
[TBL] [Abstract][Full Text] [Related]
5. THE METABOLOMICS SIGNATURE ASSOCIATED WITH RESPONSIVENESS TO STEROID THERAPY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS: A PILOT STUDY.
Chashmniam S; Kalantari S; Nafar M; Boroumandnia N
Rev Invest Clin; 2019; 71(2):106-115. PubMed ID: 31056594
[TBL] [Abstract][Full Text] [Related]
6. [Study of urinary markers of different podocytopathies by proteomic analysis].
Vinogradov AA; Chebotareva NV; Bugrova AE; Brzhozovskiy AG; Krasnova TN; Nasibullina KZ; Kononikhin AS; Moiseev SV
Ter Arkh; 2023 Aug; 95(6):457-461. PubMed ID: 38158963
[TBL] [Abstract][Full Text] [Related]
7. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis.
Shui HA; Huang TH; Ka SM; Chen PH; Lin YF; Chen A
Nephrol Dial Transplant; 2008 Jan; 23(1):176-85. PubMed ID: 17881425
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.
Trachtman H; Vento S; Herreshoff E; Radeva M; Gassman J; Stein DT; Savin VJ; Sharma M; Reiser J; Wei C; Somers M; Srivastava T; Gipson DS
BMC Nephrol; 2015 Jul; 16():111. PubMed ID: 26198842
[TBL] [Abstract][Full Text] [Related]
9. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
10. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475
[TBL] [Abstract][Full Text] [Related]
11. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis.
Erkan E; Zhao X; Setchell K; Devarajan P
Pediatr Nephrol; 2016 Apr; 31(4):581-8. PubMed ID: 26537928
[TBL] [Abstract][Full Text] [Related]
12. Urine neutrophil gelatinase-associated lipocalin and kidney injury in children with focal segmental glomerulosclerosis.
Youssef DM; El-Shal AA
Iran J Kidney Dis; 2012 Sep; 6(5):355-60. PubMed ID: 22976261
[TBL] [Abstract][Full Text] [Related]
13. A form of apolipoprotein a-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation.
Lopez-Hellin J; Cantarell C; Jimeno L; Sanchez-Fructuoso A; Puig-Gay N; Guirado L; Vilariño N; Gonzalez-Roncero FM; Mazuecos A; Lauzurica R; Burgos D; Plumed JS; Jacobs-Cacha C; Jimenez C; Fernandez A; Fernandez-Alvarez P; Torregrosa V; Nieto JL; Meseguer A; Alonso A;
Am J Transplant; 2013 Feb; 13(2):493-500. PubMed ID: 23205849
[TBL] [Abstract][Full Text] [Related]
14. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
An JN; Hyeon JS; Jung Y; Choi YW; Kim JH; Yang SH; Oh S; Kwon S; Lee SH; Cho JH; Park SH; Ha H; Kim DK; Lee JP; Hwang GS
Sci Rep; 2019 Oct; 9(1):14707. PubMed ID: 31605028
[TBL] [Abstract][Full Text] [Related]
15. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome.
Wang Y; Zheng C; Wang X; Zuo K; Liu Z
Mol Med Rep; 2017 Nov; 16(5):6276-6284. PubMed ID: 28849145
[TBL] [Abstract][Full Text] [Related]
17. NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis.
Monteiro EJ; Pereira AC; Pereira AB; Krieger JE; Mastroianni-Kirsztajn G
J Nephrol; 2006; 19(3):366-71. PubMed ID: 16874699
[TBL] [Abstract][Full Text] [Related]
18. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
Chiou YY; Lee YC; Chen MJ
Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Urinary Biomarkers in Patients With Primary Focal Segmental Glomerulosclerosis.
Zhang Q; Jiang C; Tang T; Wang H; Xia Y; Shao Q; Zhang M
Am J Med Sci; 2018 Apr; 355(4):314-321. PubMed ID: 29661344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
